Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 707 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

New insights into mpox clinical outcomes and transmission

Results of MOSAIC, a European observational study led by researchers at Pandemic Sciences Institute (PSI) and International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission.

Nuffield Department of Clinical Neurosciences researchers awarded ARIA funding for future adoption of neurotechnologies

Project teams led by Associate Professor Melanie Fleming and Professor Ben Seymour have been awarded funding from the Advanced Research + Invention Agency (ARIA) to advance research that could unlock next-generation precision neurotechnologies.

National Institute for Health and Care Research (NIHR) funded trauma project launched

Oxford University Global Surgery Group has launched a new project on reducing childhood mortality and morbidity from injuries in Tanzania and Zimbabwe, funded by the National Institute for Health and Care Research (NIHR).

Wellcome Discovery Award of £5m to fund pioneering research to combat deadly diarrhoea

The Ineos Oxford Institute has been awarded a £5 million Wellcome Discovery Award to develop vaccines against pathogens that cause diarrhoea - the third most common cause of death for children under five years of age. The work will be led by Professor Sam Sheppard, Principal Investigator of IOI’s digital microbiology programme.

First patients scanned in new study investigating traumatic brain injury in young athletes

Researchers at The Podium Institute for Sports Medicine and Technology, situated within Oxford University’s Institute of Biomedical Engineering, have recruited their first participants for a new study exploring the impact of head injuries on the brains of 11 to 18-year-olds using cutting-edge neuroimaging techniques.

Body Mass Index (BMI), blood pressure and physical activity levels in childhood linked to brain differences

Poorer cardiovascular health in childhood and adolescence may be linked to early differences in brain structure, particularly in areas of the brain known to be affected in dementia in later life, according to a new scientific study.

Inhaled vaccines could reduce viral transmission

An important step toward advancing vaccines for human use, a recent study has shown that inhaled vaccines could potentially improve efficiency and reduce viral transmission.

New study reveals link between head injuries and viruses in Alzheimer's Disease

Researchers from Oxford’s Institute of Population Ageing and the University of Manchester, and Tufts University have found that head injuries, such as those induced in sports and the military, may re-awaken dormant viruses in the brain, triggering the onset of conditions including Alzheimer’s Disease and dementia

Oxford researchers develop blood test to enable early detection of multiple cancers

Oxford University researchers have unveiled a new blood test – powered by machine learning – which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.

Umbrella review of traumatic brain injury research

Lead author Maya Ogonah outlines the findings from her research into traumatic brain injuries which has been published in the journal Nature Mental Health.

New study reveals the COVID-19 pandemic’s impact on other causes of death

An international study involving researchers at the Leverhulme Centre for Demographic Science has found significant effects of the COVID-19 pandemic on many causes of death across 24 countries.

Radical rethink of mental health support for adolescents needed – new study

Young people have given important insights into what mental health support they prefer and what does not work for them or meet their needs, as part of a major new study of thousands of adolescents.

A way to test the ability of red blood cells to deliver oxygen by measuring their shape

Scientists have developed a way of assessing the ability of red blood cells to deliver oxygen by measuring their shape. This test could improve specialist transplant and transfusion practice as well as blood banking. The research is now published open access in eBioMedicine – part of the Lancet Discovery Science.

Oxford study identifies the most effective treatments for ADHD in adults

Atomoxetine and a class of drug known as stimulants are the most effective treatments in the management of attention deficit hyperactivity disorder (ADHD) symptoms in adults, according to a new study.

Christmas Case Study

Research from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) may have had an unanticipated secondary effect by saving Christmas.

The genetic basis of fertility, family and longevity

A new review by researchers from Oxford Population Health and the University of Iceland, published in Nature Aging, reveals how your DNA shapes reproductive health, fertility, and even life expectancy.

Alethiomics – using Artemis to hunt down blood cancers

Spin-out company Alethiomics, focused on the development of innovative treatments for blood cancers, is Oxford through-and-through. Founded by Clinician Scientists who run neighbouring laboratories at the University’s MRC Weatherall Institute of Molecular Medicine, seed financed by Oxford Science Enterprises and located at the BioEscalator, the company’s early years have been immersed in the Oxford innovation ecosystem.

Oxford and partners lead on two new MRC Centres to create cutting-edge gene therapies

Oxford University researchers are to lead and co-lead on two MRC research centres, which are being launched to develop new advanced treatments for currently untreatable diseases.

First vaccine against blood-stage malaria is well-tolerated and offers effective protection

The results of a clinical trial into a new malaria vaccine candidate (RH5.1/Matrix-MTM) show it is well-tolerated and offers effective protection against the blood-stage of the disease - the first inoculation to do so.

Wearable devices can help predict five year risk of falls for people with Parkinson’s Disease

A new study from the University of Oxford demonstrates how clinicians could use data to predict the risk of falls in people with Parkinson’s Disease (PD) to help improve effective longer term care planning.

Load More